Official UK procurement notice
Public Health Medicines Optimisation Service
Authority: The North Yorkshire Council (Local council)
What is being bought
Published requirement descriptionPublic Health Medicine Optimisation and Advisory Service (PHMOAS - the Services ) will provide up to date medicines advice and guidance to the Council.
CPV: Pharmacy services
The lotProcurement structure
single lot · no lot value publishedLot #1The Public Health Medicine Optimisation and Advisory Service (PHMOAS - the Services )…Awarded
The Public Health Medicine Optimisation and Advisory Service (PHMOAS - the Services ) will provide up to date medicines advice and guidance to the Council , to ensure the safe and effective use of medicines across our services, and to support delivery of our statutory responsibilities. Through the provision of pharmaceutical advice from a NHS Band 8b pharmacist, and supporting workforce to maintain the provision of a prescribing dashboard.
The contract will be in place between 01/07/2026 to 30/06/2027 for a period of 12 months.
This notice is confirmation of an award having been made using the Provider Selection Regime Urgent Award Process.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 1 Jul 2026, 14:10 BST
- Last source update
- 1 Jul 2026, 14:10 BST
- Authority reference
776-NYC-HA- FTS notice number
2026/S 000-061783- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06c15fFind a Tender
- Why no open competition
Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive
- Published justification
Termination of the existing Public Health Medicines Service contract is required due to significant and unforeseen structural changes, resulting in the imminent loss of service provision by the supplier.
The loss of pharmaceutical expertise presents a risk to continuity, legality, and patient safety, and continued reliance on the current provider is therefore not viable or proportionate and a Direct Award is essential to maintain continuity of service. Sufficient time was not available for alternative arrangements via competition. The urgent Direct Award is for a short time period, until new arrangements are put in to place.
Publisher note: This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. Termination of the existing Public Health Medicines Service contract is required due to significant and unforeseen structural change, resulting in the imminent loss of service provision by the supplier. Therefore, the contracts were awarded using the urgent award procedure.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| PHARMACEUTICAL HEALTH CONSULTANTS LIMITED. | £30,000 † | — | Awarded |
Contracts
Public Health Medicines Optimisation Service · PHARMACEUTICAL HEALTH CONSULTANTS LIMITED.
- Signed
- 1 Jul 2026
- Value
- £30,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 0 electronic | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High Court of England and WalesReview body
Bidders & participating suppliers
1 commercial party on the notice- PHARMACEUTICAL HEALTH CONSULTANTS LIMITED.Awarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.